Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.
Levin, J.I., Chen, J.M., Laakso, L.M., Du, M., Schmid, J., Xu, W., Cummons, T., Xu, J., Jin, G., Barone, D., Skotnicki, J.S.(2006) Bioorg Med Chem Lett 16: 1605-1609
- PubMed: 16426848 
- DOI: https://doi.org/10.1016/j.bmcl.2005.12.020
- Primary Citation of Related Structures:  
2A8H - PubMed Abstract: 
A series of thiomorpholine sulfonamide hydroxamate TACE inhibitors, all bearing propargylic ether P1' groups, was explored. In particular, compound 5h has excellent in vitro potency against isolated TACE enzyme and in cells, oral activity in a model of TNF-alpha production and a collagen-induced arthritis model, was selected as a clinical candidate for the treatment of RA.
Organizational Affiliation: 
Wyeth Research, 401 N. Middletown Road, Pearl River, NY 10965, USA. levinji@wyeth.com